Related Experiment Video

Updated: Jun 7, 2025

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
12:19

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks

Published on: November 10, 2016

8.2K

The synergy between alkylating agents and ERCC1-XPF inhibitors is p53 dependent

Gloria Ciniero1,2, Tiago Marques Pedro2, Charles Dumontet2

  • 1PolitoBIOMedLab, Department of Mechanical and Aerospace Engineering, Politecnico di Torino, Turin, Italy.

Fundamental & Clinical Pharmacology
|November 9, 2024
PubMed
Abstract

Insights

This study characterizes an inhibitor targeting DNA repair proteins ERCC1 and XPF. The inhibitor enhances chemotherapy efficacy, particularly in tumors with wild-type p53, offering a new strategy for cancer treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genomic Stability

Background:

  • DNA repair is crucial for genomic stability but can reduce chemotherapy effectiveness by removing drug-induced DNA damage.
  • Inhibiting DNA repair is a promising strategy to enhance chemotherapy efficacy in cancer patients.

Purpose of the Study:

  • To further characterize an inhibitor targeting the ERCC1-XPF interaction, key proteins in nucleotide excision repair.
  • To evaluate the inhibitor's synergistic effects with platinum-based chemotherapy.

Main Methods:

  • Utilized various cell lines for co-incubation studies.
  • Assessed cell survival and DNA repair capacities.
  • Investigated the role of ERCC1, XPF, and p53 expression in drug response.

Main Results:

  • The ERCC1-XPF inhibitor demonstrated synergy with platinum derivatives beyond those previously reported.
  • Synergy was absent in cells lacking ERCC1 or XPF expression.
  • Enhanced drug activity was observed exclusively in cells expressing wild-type p53.

Conclusions:

  • Confirmed the mechanism of action for the ERCC1-XPF inhibitor.
  • Provided additional data supporting the use of this inhibitor to potentiate existing cancer therapies.
  • Highlighted the importance of ERCC1, XPF, and p53 status in predicting treatment response.
Keywords:
DNA repairERCC1XPFcancerinhibitorp53

More Related Videos

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage10:44

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

10.2K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.0K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K